Impact of busulfan- versus treosulfan-based conditioning on the incidence of sinusoidal obstruction syndrome/veno-occlusive disease after allogeneic hematopoietic cell transplantation: a dual-center real-world study [0.03%]
基于 busesulfan-和treosulphan-预处理对allo-HSCT后肝小静脉闭塞性病发病风险的影响：一项来自两家移植中心的真实世界研究
Lorenzo Lazzari,Aitana Balaguer-Roselló,Alessandro Bruno et al.
Lorenzo Lazzari et al.
Late hematologic toxicity after CAR T-cell therapy in large B-cell lymphoma: incidence, risk factors, and clinical impact [0.03%]
大B细胞淋巴瘤CAR-T细胞治疗后的晚期血液学毒性：发生率、风险因素和临床影响
Magdalena Corona,Samantha Brown,Kai Rejeski et al.
Magdalena Corona et al.
Late Immune Effector Cell-Associated HematoToxicity (ICAHT) is a recognized complication following CAR T therapy, yet their incidence and clinical consequences remain poorly defined. We assessed early and late hematotoxicity in 290 patients...
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis [0.03%]
用于治疗AML的氟达拉滨/美法仑预处理和他克莫司/西罗莫司预防GVHDallo-HCT的长期生存结局
Amandeep Salhotra,Dongyun Yang,Monzr M Al Malki et al.
Amandeep Salhotra et al.
Allogeneic hematopoietic cell transplantation (allo-HCT) is increasingly offered as a consolidation strategy for older/infirm patients with acute myeloid leukemia (AML). Fludarabine/melphalan (Flu/Mel) conditioning is associated with effect...
Long-term disease control of monomorphic epitheliotrophic intestinal T-cell lymphoma (MEITL) with CNS involvement in a caucasian patient by allogeneic hematopoietic cell transplantation [0.03%]
allo-HCT治疗CNS受侵的肠黏膜上皮细胞单形性T细胞淋巴瘤1例报告
Markus Lindauer,Florian Reissfelder,Ute Hegenbart et al.
Markus Lindauer et al.
Real-world medical expenses of hematopoietic stem cell transplantation in Japan: a nationwide database study [0.03%]
日本造血干细胞移植的现实世界医疗费用：一项全国数据库研究
Mizuki Watanabe,Shosuke Ohtera,Junya Kanda et al.
Mizuki Watanabe et al.
Outcomes of hematopoietic stem cell transplantation for patients with monomorphic epitheliotropic intestinal T-cell lymphoma: retrospective study from the Adult Lymphoma Working Group of the Japan Society for Transplantation and Cellular Therapy [0.03%]
日本移植和细胞治疗学会成人淋巴瘤工作组的单形上皮亲嗜性肠T细胞淋巴瘤患者造血干细胞移植结局的回顾性研究
Kodai Kuriyama,Mizuki Watanabe,Takeshi Okatani et al.
Kodai Kuriyama et al.
Current therapeutics for sclerotic and fibrotic manifestations of chronic graft-versus-host disease [0.03%]
慢性移植物抗宿主病硬化和纤维化表现的当前治疗方法
Hannah Choe,Zachariah DeFilipp
Hannah Choe
Chronic graft-versus-host disease (cGVHD) is a long-term, heterogeneous immunologic complication of allogeneic hematopoietic cell transplantation. A subset of patients with cGVHD develop progressive fibrosis with highly morbid manifestation...
Author response: comparative efficacy of HSCT strategies in pediatric aplastic anemia [0.03%]
作者回复：儿童再生障碍性贫血HSCT方案疗效比较
Zuo-Feng Li,Hao Xiong,Zhi Chen et al.
Zuo-Feng Li et al.